[{"orgOrder":0,"company":"Bonerge Lifescience","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Nutrition and Weight Loss","country":"CHINA","productType":"Probiotic","year":"2025","type":"Inapplicable","leadProduct":"Akkermansia Muciniphila","moa":"Amuc_1100 protein","graph1":"Nutrition and Weight Loss","graph2":"Approved FDF","graph3":"Bonerge Lifescience","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Nutrition & Weight Loss","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Bonerge Lifescience \/ Undisclosed","highestDevelopmentStatusID":"15","companyTruncated":"Bonerge Lifescience \/ Undisclosed"}]

Find Clinical Drug Pipeline Developments & Deals by Bonerge Lifescience

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Neuroscience
                          Not Confirmed
                          Neuroscience
                          Not Confirmed

                          Details : Akkermansia Muciniphila, a probiotic targeting Amuc_1100 protein, shows promise in improving metabolic health.

                          Product Name : Amuctive

                          Product Type : Probiotic

                          Upfront Cash : Inapplicable

                          October 24, 2025

                          Lead Product(s) : Akkermansia Muciniphila

                          Therapeutic Area : Nutrition and Weight Loss

                          Highest Development Status : Approved FDF

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank